{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:40:38Z","timestamp":1778658038055,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jamda.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jamda.2014.03.005","type":"journal-article","created":{"date-parts":[[2014,4,19]],"date-time":"2014-04-19T21:00:16Z","timestamp":1397941216000},"page":"620-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Antihypertensive Treatment in People With Dementia"],"prefix":"10.1016","volume":"15","author":[{"given":"Veronika","family":"van der Wardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pip","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4920-6718","authenticated-orcid":false,"given":"Rowan","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8506-7786","authenticated-orcid":false,"given":"John","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2014.03.005_bib1","article-title":"Dementia","year":"2012","journal-title":"A\u00a0public health priority"},{"key":"10.1016\/j.jamda.2014.03.005_bib2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2014.03.005_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medicinal Research Council trial of treatment of hypertension in older adults\u2014Principal results","volume":"304","author":"Meade","year":"1992","journal-title":"Br Med J"},{"key":"10.1016\/j.jamda.2014.03.005_bib4","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug-treatment in older persons with isolated hypertension\u2014Final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","author":"Probstfield","year":"1991","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jamda.2014.03.005_bib5","first-page":"CD000028","article-title":"Pharmacotherapy for hypertension in the elderly (Review)","author":"Musini","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2014.03.005_bib6","article-title":"The treatment of hypertension in care home residents: A systematic review of observational studies","author":"Welsh","year":"2013","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2014.03.005_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A\u00a0typology of reviews: An analysis of 14 review types and associated methodologies","volume":"26","author":"Grant","year":"2009","journal-title":"Health Inform Libraries J"},{"key":"10.1016\/j.jamda.2014.03.005_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjopharm.2009.11.001","article-title":"Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review","volume":"7","author":"Shah","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jamda.2014.03.005_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/2040622310397636","article-title":"Latest advances on interventions that may prevent, delay, or ameliorate dementia","volume":"2","author":"Wilson","year":"2011","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jamda.2014.03.005_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-2012-121090","article-title":"Associations of angiotensin targeting antihypertensive drugs with mortality and hospitalization in primary care patients with dementia","volume":"33","author":"Kehoe","year":"2013","journal-title":"J\u00a0Alzheimer Dis"},{"key":"10.1016\/j.jamda.2014.03.005_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0022-510X(00)00301-4","article-title":"The Scandinavian Multi-Infarct Dementia Trial: A double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia","volume":"175","author":"Pantoni","year":"2000","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jamda.2014.03.005_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.STR.0000155686.73908.3e","article-title":"Efficacy and safety of nimodipine in subcortical vascular dementia: A randomized placebo-controlled trial","volume":"36","author":"Pantoni","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jamda.2014.03.005_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-510X(00)00300-2","article-title":"Efficacy and safety of nimodipine in subcortical vascular dementia: A subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial","volume":"175","author":"Pantoni","year":"2000","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jamda.2014.03.005_bib14","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/gps.2638","article-title":"Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: Results from a 6-week open label study","volume":"26","author":"Kennelly","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.03.005_bib15","unstructured":"Shaw FE. Falls in older people with dementia. Canada: Geriatrics and Aging 2003. Available at: http:\/\/ga.geriatricsandaging.ca\/files\/content\/2003\/August\/0607dementiafall.pdf. Accessed January 21,\u00a02014."},{"key":"10.1016\/j.jamda.2014.03.005_bib16","doi-asserted-by":"crossref","first-page":"407.e1","DOI":"10.1016\/j.jamda.2011.11.003","article-title":"Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: A 2-year prospective study in 686 patients of the REAL.FR Study","volume":"13","author":"Sourdet","year":"2012","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2014.03.005_bib17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1046\/j.1532-5415.2003.51404.x","article-title":"Dementia as a risk factor for falls and fall injuries among nursing home residents","volume":"51","author":"Van Doorn","year":"2003","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2014.03.005_bib18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/pds.2176","article-title":"Risk of falls associated with antihypertensive medication: Self-controlled case series","volume":"20","author":"Gribbin","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2014.03.005_bib19","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Int Med"},{"key":"10.1016\/j.jamda.2014.03.005_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03324674","article-title":"Characteristics associated with falls in patients with dementia in a psychogeriatric ward","volume":"19","author":"Eriksson","year":"2007","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jamda.2014.03.005_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF03324739","article-title":"Characteristics associated with falls in patients with dementia in a psychogeriatric ward","volume":"19","author":"Eriksson","year":"2007","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jamda.2014.03.005_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1041610208007837","article-title":"Risk factors for falls among residents with dementia living in group dwellings","volume":"21","author":"Pellfolk","year":"2009","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2014.03.005_bib23","doi-asserted-by":"crossref","unstructured":"Allan LM, Ballard CG, Rowan EN, Kenny RA. Incidence and prediction of falls in dementia: A prospective study in older people. PLoS One 2009;4:e5521. Available at http:\/\/onlinelibrary.wiley.com\/o\/cochrane\/clcentral\/articles\/001\/CN-00698001\/frame.html. Accessed January 21, 2014.","DOI":"10.1371\/journal.pone.0005521"},{"key":"10.1016\/j.jamda.2014.03.005_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ageing\/25.1.22","article-title":"Predictors of fall-related injuries among community-dwelling elderly people with dementia","volume":"25","author":"Asada","year":"1996","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2014.03.005_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/0269881104042625","article-title":"Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients","volume":"18","author":"Herrmann","year":"2004","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jamda.2014.03.005_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.wad.0000155067.16313.5e","article-title":"Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: A placebo-controlled study","volume":"19","author":"Peskind","year":"2005","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jamda.2014.03.005_bib27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/JGP.0b013e3181ab8c61","article-title":"Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression","volume":"17","author":"Wang","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.03.005_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00002093-199509040-00010","article-title":"Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients","volume":"9","author":"Shankle","year":"1995","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jamda.2014.03.005_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/089198878800100408","article-title":"Propranolol for the control of disruptive behavior in senile dementia","volume":"1","author":"Weiler","year":"1988","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"issue":"3","key":"10.1016\/j.jamda.2014.03.005_bib30","first-page":"CD001841","article-title":"First-line drugs for hypertension","author":"Wright","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.jamda.2014.03.005_bib31","first-page":"CD002003","article-title":"Beta-blockers for hypertension","author":"Wiysonge","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2014.03.005_bib32","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/01.hjh.0000249685.58370.28","article-title":"How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis","volume":"24","author":"Bradley","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jamda.2014.03.005_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/JCP.0b013e31820482c4","article-title":"Beta-Blockers and the Risk of Incident Depression in the Elderly","volume":"31","author":"Luijendijk","year":"2011","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jamda.2014.03.005_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0278-5846(90)90005-2","article-title":"Nimodipine in the treatment of old age dementias","volume":"14","author":"Ban","year":"1990","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jamda.2014.03.005_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-0327(98)00070-6","article-title":"The prevalence of depression in Alzheimer's disease and vascular dementia in a population sample","volume":"52","author":"Newman","year":"1999","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jamda.2014.03.005_bib36","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1098-3597(04)90014-2","article-title":"Sleep disorders in Alzheimer's disease and other dementias","volume":"6","author":"Bliwise","year":"2004","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.jamda.2014.03.005_bib37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jagp.2012.08.001","article-title":"Subtypes of sleep problems in patients\u00a0with Alzheimer disease","volume":"22","author":"Ownby","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.03.005_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MNH.0b013e3283402eb5","article-title":"Antihypertensive therapy for patients with obstructive sleep apnea","volume":"20","author":"Ziegler","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jamda.2014.03.005_bib39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.archger.2010.11.006","article-title":"Sleep disturbance is associated with decreased daily activity and impaired nocturnal reduction of blood pressure in dementia patients","volume":"53","author":"Suzuki","year":"2011","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jamda.2014.03.005_bib40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbi.2005.11.002","article-title":"Hostility and pain are related to inflammation in older adults","volume":"20","author":"Graham","year":"2006","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jamda.2014.03.005_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004872-200203000-00024","article-title":"Changes in pain perception during treatment with angiotensin converting enzyme-inhibitors and angiotensin II type 1 receptor blockade","volume":"20","author":"Guasti","year":"2002","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jamda.2014.03.005_bib42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1055\/s-0029-1220233","article-title":"Anti hypertensive treatment and renal function in geriatric emergency patients","volume":"134","author":"Bolbrinker","year":"2009","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1016\/j.jamda.2014.03.005_bib43","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1532-5415.2010.03006.x","article-title":"The effect of medication use on urinary incontinence in community-dwelling elderly women","volume":"58","author":"Ruby","year":"2010","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2014.03.005_bib44","first-page":"255","article-title":"Co-morbidities and incontinence in an elderly long-term care population. Conference, 29th Annual Scientific Meeting of the American Urogynecologic Society, Chicago, IL","volume":"14","author":"Ridgeway","year":"2008","journal-title":"J\u00a0Pelvic Med Surgery"},{"key":"10.1016\/j.jamda.2014.03.005_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/gps.1312","article-title":"Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy","volume":"20","author":"Rozzini","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.03.005_bib46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1099-1166(200003)15:3<242::AID-GPS110>3.0.CO;2-7","article-title":"Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications","volume":"15","author":"Grossberg","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.03.005_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/11530300-000000000-00000","article-title":"Factors associated with serious adverse reactions to cholinesterase inhibitors: A study of spontaneous reporting","volume":"24","author":"Pariente","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jamda.2014.03.005_bib48","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2165\/00002018-200730110-00005","article-title":"Drug interactions with cholinesterase inhibitors\u2014An analysis of the French Pharmacovigilance Database and a comparison of two national drug formularies (Vidal, British National Formulary)","volume":"30","author":"Tavassoli","year":"2007","journal-title":"Drug Safety"},{"key":"10.1016\/j.jamda.2014.03.005_bib49","unstructured":"Model Of Care Polypharmacy Working Group. Polypharmacy Guidance. Scottish Government Health and Social Care Directorates (ed.) 2012; Available at: http:\/\/www.central.knowledge.scot.nhs.uk\/upload\/Polypharmacy%20full%20guidance%20v2.pdf. Accessed January 20,\u00a02014."},{"key":"10.1016\/j.jamda.2014.03.005_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1532-5415.2001.4930277.x","article-title":"The appropriateness of drug use in an older nondemented and demented population","volume":"49","author":"Giron","year":"2001","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2014.03.005_bib51","unstructured":"Montastruc F, Gardette V, Cantet C, et\u00a0al. Potentially inappropriate medication use among patients with Alzheimer disease in real.fr: Be aware of atropinic and benzodiazepine drugs! Pharmacoepidemiology and Drug Safety 2013; Conference, 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, ICPE, 2012 Barcelona, Spain."},{"key":"10.1016\/j.jamda.2014.03.005_bib52","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrcardio.2010.161","article-title":"The relationship between blood pressure and cognitive function","volume":"7","author":"Novak","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jamda.2014.03.005_bib53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10286-011-0145-3","article-title":"A\u00a0review of orthostatic blood pressure regulation and its association with mood and cognition","volume":"22","author":"Perlmuter","year":"2012","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.jamda.2014.03.005_bib54","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/gps.1861","article-title":"The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies","volume":"23","author":"Andersson","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.03.005_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2010.08.056","article-title":"Relationship between orthostatic hypotension and cognitive impairment in the elderly","volume":"299","author":"Mehrabian","year":"2010","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jamda.2014.03.005_bib56","article-title":"The evidence for treating hypertension in older people with dementia: A systematic review","author":"Beishon","year":"2013","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jamda.2014.03.005_bib57","series-title":"Polypharmacy and medicines optimisation - Making it safe and sound","author":"Duerden","year":"2013"},{"key":"10.1016\/j.jamda.2014.03.005_bib58","first-page":"2021","article-title":"Medication withdrawal trials in people aged 65 and older: A systematic review","volume":"25","author":"Iver","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2014.03.005_bib59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0895-7061(00)01246-2","article-title":"A\u00a0systematic review of predictors of maintenance of normotension after withdrawal of antihypertensive drugs","volume":"14","author":"Nelson","year":"2001","journal-title":"Am J Hypertens"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861014001418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861014001418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T14:24:03Z","timestamp":1565360643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861014001418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1525861014001418"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2014.03.005","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihypertensive Treatment in People With Dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2014.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AMDA \u2013 The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}